Your browser doesn't support javascript.
loading
Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk.
Ingueneau, Cécile; Hollstein, Tim; Grenkowitz, Thomas; Ruidavets, Jean-Bernard; Kassner, Ursula; Duparc, Thibaut; Combes, Guillaume; Perret, Bertrand; Genoux, Annelise; Schumann, Friederike; Bobbert, Thomas; Steinhagen-Thiessen, Elisabeth; Martinez, Laurent O.
Afiliação
  • Ingueneau C; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Hollstein T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany; Division of Endocrinology, Diabetology and Clinical Nutrition, Department of Internal Medicine 1, University of Kiel, Arnold Heller Straße 3, Kiel 24105, Germany. Electronic address: tim.ho
  • Grenkowitz T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Ruidavets JB; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1027, Toulouse, France.
  • Kassner U; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Duparc T; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
  • Combes G; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
  • Perret B; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Genoux A; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Schumann F; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Bobbert T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Steinhagen-Thiessen E; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Martinez LO; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
Vascul Pharmacol ; 135: 106804, 2020 12.
Article em En | MEDLINE | ID: mdl-32987194
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Serina Proteinase / Aterosclerose / Dislipidemias / Inibidores de PCSK9 / HDL-Colesterol / Anticolesterolemiantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Serina Proteinase / Aterosclerose / Dislipidemias / Inibidores de PCSK9 / HDL-Colesterol / Anticolesterolemiantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article